Full visibility into the global pharmaceutical manufacturing ecosystem. Nexigen surfaces qualified suppliers, benchmarks manufacturers, monitors compliance, and flags supply-chain risk before it disrupts your portfolio.
Branded, generic, specialty, and biosimilar makers with hierarchy mapping and benchmarking.
Global facilities with FDA/EMA inspections, GMP status, warning letters, and import alerts.
API/KSM supply mapping, sourcing concentration, and single-source dependency detection.
140+ categories including cell/gene therapy, mRNA, and ADC, with CDMO benchmarking.
Visualize supplier ecosystems and concentration to reveal hidden dependencies.
Monitors geographic, regulatory, and geopolitical risk and simulates disruptions.
Branded, generic, specialty, and biosimilar makers with hierarchy mapping and benchmarking.
Global facilities with FDA/EMA inspections, GMP status, warning letters, and import alerts.
API/KSM supply mapping, sourcing concentration, and single-source dependency detection.
140+ categories including cell/gene therapy, mRNA, and ADC, with CDMO benchmarking.
Visualize supplier ecosystems and concentration to reveal hidden dependencies.
Monitors geographic, regulatory, and geopolitical risk and simulates disruptions.
Warning-letter alerts arrive within 48 hours of FDA or EMA publication — not monthly digest.
API concentration-risk model covers 400+ active ingredients with geographic heat maps.
Capacity expansion data sourced from public filings, earnings calls, and industry events.
Shortlist exports formatted for vendor qualification workflows.
Natural-language questions Nexigen answers in seconds:
Book a walkthrough with the right specialist and we'll tailor it to your therapeutic area and the questions your team is asking.
